Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In vitro dissolution methodologies that adequately capture the oral bioperformance of solid dosage forms are critical tools needed to aid formulation development. Such methodologies must encompass important physiological parameters and be designed with drug properties in mind. Two‐phase dissolution apparatuses, which contain an aqueous phase in which the drug dissolves (representing the dissolution/solubility component) and an organic phase into which the drug partitions (representing the absorption component), have the potential to provide meaningful predictions of in vivo oral bioperformance for some BCS II, and possibly some BCS IV drug products. Before such an apparatus can be evaluated properly, it is important to understand the kinetics of drug substance partitioning from the aqueous to the organic medium. A mass transport analysis was performed of the kinetics of partitioning of drug substance solutions from the aqueous to the organic phase of a two‐phase dissolution apparatus. Major assumptions include pseudo‐steady‐state conditions, a dilute aqueous solution and diffusion‐controlled transport. Input parameters can be measured or estimated a priori. This paper presents the theory and derivation of our analysis, compares it with a recent kinetic approach, and demonstrates its effectiveness in predicting in vitro partitioning profiles of three BCS II weak acids in four different in vitro two‐phase dissolution apparatuses. Very importantly, the paper discusses how a two‐phase apparatus can be scaled to reflect in vivo absorption kinetics and for which drug substances the two‐phase dissolution systems may be appropriate tools for measuring oral bioperformance. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 3×
“estimated A/V to be equal to 2/r, where r is the radius of the small intestine [3].”
Self-citation
Cited by
Mudie, D. M., Murray, K., Hoad, C. L., Pritchard, S. E., Garnett, M. C., Amidon, G. L., Gowland, P. A., Spiller, R. C., Amidon, G. E., & Marciani, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500210c · Cited by 486
Self-citationTsume, Y., Mudie, D. M., Langguth, P., Amidon, G. E., & Amidon, G. L. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.01.009 · Cited by 350
Self-citationDrug permeability profiling using cell-free permeation tools: overview and applications
Berben, P., Bauer-Brandl, A., Brandl, M., Faller, B., Flaten, G. E., Jacobsen, A.-C., Brouwers, J., & Augustijns, P. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.016 · Cited by 199
“The physiological area-to-volume ratio is estimated to be between 1.9 cm − 1 and 2.3 cm − 1 (Mudie et al., 2012).”
InfluentialLipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Keemink, J., Mårtensson, E., & Bergström, C. A. S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00811 · Cited by 82
PermeaLoop™, a novel in vitro tool for small-scale drug-dissolution/permeation studies
Sironi, D., Rosenberg, J., Bauer-Brandl, A., & Brandl, M. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.04.042 · Cited by 36
Metadata
- Authors
- Mudie, D. M., Shi, Y., Ping, H., Gao, P., Amidon, G. L., & Amidon, G. E.
- Venue
- Biopharmaceutics & Drug Disposition
- Publisher
- Wiley
- Published
- 2012-09-04
- Volume
- 33
- Issue
- 7
- Pages
- 378-402
- ISSN
- 0142-2782 (ISSN-L)
- 1099-081X
- OpenAlex
- W2142835382
- Cited by
- 91
- References
- 1
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.